Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

AstraZeneca
Pharmaceuticals
Pfizer
Sanofi
Novo Nordisk
AbbVie
Johnson & Johnson
GSK
Topics

Advertisement

AstraZeneca

Share

Top Latest Popular

In the last 4 hours

[BIO USA 2026] AstraZeneca expands hunt for external innovation beyond single-asset licensing Korea Biomedical Review 01:40

In the last 6 hours

Unilever among firms joining coalition for hourly matching carbon-free electricity edie.net 00:06

Sunday

3 UK Stocks Trading Below Cash Flow Value Simply Wall St 08:03 Sun, 21 Jun

Advertisement

Advertisement

Friday

India could be on the radar for AstraZeneca’s oral GLP-1 drug: MD The Hindu Business Line 15:29 Fri, 19 Jun

Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note Zacks 00:20 Fri, 19 Jun

Thursday

Making change happen at HBA Cambridge’s Innovation Leadership Forum at Homerton College Cambridge Independent 18:22 Thu, 18 Jun

Celonis London PI Day - AstraZeneca and Arm reveal how process intelligence underpins AI success Diginomica 17:23 Thu, 18 Jun

Wednesday

The terrifying number of patients who have suffered Covid jab complications revealed, after NHS pharmacist left paralysed by vaccine takes his own life MailOnline 14:29 Wed, 17 Jun

The Zacks Analyst Blog Highlights Applied Materials, GE, AstraZeneca, Team and Applied Energetics Zacks 09:46 Wed, 17 Jun

Advertisement

In the last month

Top Stock Reports for Applied Materials, GE & AstraZeneca Zacks 22:34 Tue, 16 Jun

FDA Accepts AstraZeneca's Filing for Expanded Use of Ultomiris Zacks 19:00 Tue, 16 Jun

AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold? Zacks 16:17 Tue, 16 Jun

Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy WebWire 16:05 Mon, 15 Jun

AstraZeneca's Truqap Wins FDA Nod for Prostate Cancer Indication Zacks 15:06 Mon, 15 Jun

AstraZeneca Joins zero Prostate Cancer's Historic 'Blitz the Barriers' Initiative as a Founding Partner PR Newswire (Press Release) 15:03 Mon, 15 Jun

AZ's Truqap and Roche assay cleared for PTEN prostate cancer pharmaphorum 08:48 Mon, 15 Jun

Astrazeneca secures US approval for Truqap combo in PTEN‑deficient prostate cancer ShareCast 08:35 Mon, 15 Jun

FDA TRUQAP Approval Highlights AstraZeneca’s Precision Oncology And Valuation Gap Simply Wall St 10:26 Sun, 14 Jun

Truqap® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer Business Wire (Press Release) 23:49 Fri, 12 Jun

AstraZeneca Builds Up Oncology As It Looks To 2030 Scrip Pharma Intelligence 23:14 Fri, 12 Jun

Truqap combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer AstraZeneca (Press Release) 19:03 Fri, 12 Jun

Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know Zacks 00:21 Fri, 12 Jun

UAE first to approve new oral breast cancer drug Gulf News 11:01 Thu, 11 Jun

AstraZeneca and Roche battle for a cancer breakthrough Investors Chronicle 07:52 Thu, 11 Jun

AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer The Times of India 07:17 Thu, 11 Jun

ADA 2026: AstraZeneca To Move Fast On Obesity And Heart Pill Combinations Scrip Pharma Intelligence 17:47 Wed, 10 Jun

McCormick Adds Cindy Hoots To Its Board Of Directors Checkout Magazine 11:55 Wed, 10 Jun

ADA26: AstraZeneca unveils positive data for Phase III-ready oral GLP-1RA Clinical Trials Arena 15:19 Tue, 09 Jun

STAT Plus: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more STAT 14:43 Tue, 09 Jun

AstraZeneca's obesity drug shows promise as analysts see upside beyond consensus Invezz 14:36 Tue, 09 Jun

Lung Cancer Research Foundation and AstraZeneca Announce Open Call for Research Proposals with Focus on Small Cell Lung Cancer PR Newswire (Press Release) 14:31 Tue, 09 Jun

AstraZeneca reprimanded over LinkedIn likes once again FiercePharma 11:39 Tue, 09 Jun

ADA: AZ reveals oral GLP-1 data in obesity, diabetes pharmaphorum 10:59 Tue, 09 Jun

Encouraging trial results for AstraZeneca's new weight-loss pill France 24 03:08 Tue, 09 Jun

ADA 2026: AstraZeneca Advances Oral GLP-1 Elecoglipron Into Phase III After Positive Trial Data Scrip Pharma Intelligence 21:49 Mon, 08 Jun

expert reaction to two studies looking at AstraZeneca’s GLP 1 pill, elecoglipron, for reducing weight and lowering blood-sugar in adults with and without type 2 diabetes Science Media Centre 21:40 Mon, 08 Jun

AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial Rock Hill Herald 21:37 Mon, 08 Jun

Hong Kong's urban development near China border draws AstraZeneca, others Nikkei Asian Review 21:29 Mon, 08 Jun

STAT Plus: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials STAT 21:25 Mon, 08 Jun

Elecoglipron, an oral small molecule GLP-1 RA, moves to Phase III programme and unlocks next chapter in AstraZeneca’s cardiometabolic and kidney portfolio AstraZeneca (Press Release) 21:22 Mon, 08 Jun

Advertisement

Advertisement

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis